Also trades as: BEAT (NASDAQ) · $vol 0M
BEATW NASDAQ
HeartBeam, Inc.
1W: +17.1%
1M: -29.9%
3M: -72.6%
YTD: -97.4%
1Y: -96.5%
3Y: -98.7%
$0.01
+0.00 (+1.23%)
Weekly Expected Move ±46.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-11-17
Earliest Filing
2025-02-18
Latest Filing
partner: 8
investor: 2
supplier: 1
Counterparties (Filed by BEATW)
11 relationshipsCompanies named in BEATW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Public Ventures, LLC dba MDB Capital | — | partner | Entered into an underwriting agreement for a firm commitment offering of 5,882,353 shares of common stock. | 2025-02-18 | View |
| Public Ventures, LLC | — | partner | Sales agent for the PV Sales Agreement | 2024-05-02 | View |
| A.G.P./Alliance Global Partners | — | partner | Prior sales agent whose agreement was terminated | 2024-05-02 | View |
| Maverick Capital Partners, LLC | — | investor | Investor in securities purchase agreement and note purchase agreement for convertible notes. | 2023-03-03 | View |
| LIVMOR, Inc. | — | partner | Partnered to build a Company-branded version of LIVMOR's Halo+ FDA cleared turnkey solution for remote patient monitorin | 2022-08-08 | View |
| Triple Ring Technologies, Inc. | — | partner | Partnered with HeartBeam, Inc. for co-development of a Telehealth 3D vector ECG collection device. | 2022-03-10 | View |
| OpenSky Opportunities Fund Ltd. | — | investor | Purchased 58,000 units consisting of common stock and warrants in a private placement for $6 per unit. | 2022-02-22 | View |
| LIVMOR, Inc. | — | partner | Partnership to build a HeartBeam-branded version of LIVMOR's Halo+ remote patient monitoring solution. | 2022-02-02 | View |
| Ximedica, LLC | — | supplier | Prior supplier for FDA 510(k) submission services whose agreement was terminated. | 2022-02-02 | View |
| The Benchmark LLC | — | partner | Underwriter for the IPO | 2021-11-17 | View |
| VStock Transfer, LLC | — | partner | Warrant agent for the IPO | 2021-11-17 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-14 | Material Agreement; Exhibits | Agreement | View |
| 2026-08-06 | Officer/Director Change; Exhibits | View | |
| 2026-08-03 | Shareholder Vote | View | |
| 2026-07-02 | Delisting Notice | View | |
| 2026-06-24 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-06-22 | Officer/Director Change; Exhibits | View | |
| 2026-04-16 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2025-11-21 | Other Events | View | |
| 2025-07-16 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-05-05 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-04-25 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-02-26 | Other Events; Financial Statements and Exhibits | View | |
| 2025-02-18 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2024-10-23 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure | View | |
| 2024-09-10 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-06-18 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2024-05-02 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Financial St | Agreement | View |
| 2024-02-05 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2023-07-26 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2023-06-08 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR